top of page

TECHNOLOGY

 

Photo­bio­modulation, explained

 

Photobiomodulation (PBM) uses red and near-infrared light to interact with tissue. VOLTA F3 combines three wavelengths in one clinician-controlled platform.

 

● 650 nm   ● 810 nm   ● 980 nm

CLASS 4 LASER THERAPY

 

What Class 4 means in practice

 

Class 4 is a laser safety category, not a treatment claim. It describes devices with higher optical output. In therapy, higher output lets the clinician deliver a chosen dose in less time, and it calls for controlled use.

Dose and time

Dose depends on power and time. A higher-output system can reach the same dose sooner, and the clinician decides the dose.

Controlled use

Used by trained healthcare professionals, with eye protection for patient and staff and the safety steps in the instructions for use.

Registered in Malaysia

VOLTA F3 is registered with the Medical Device Authority, Malaysia. MDA registration GC6440126-238777.

PHOTOBIOMODULATION

 

Light that tissue can use

 

In photobiomodulation, light energy is absorbed by chromophores within cells, such as cytochrome c oxidase in the mitochondria. Wavelength determines how deeply light travels into tissue, which is why VOLTA F3 offers three.

 

Research on the mechanisms and clinical use of photobiomodulation is summarised on the Evidence page.

MULTI-WAVELENGTH TECHNOLOGY

 

One platform, three tissue depths

 

VOLTA F3 delivers 650, 810 and 980 nm, each controlled independently, so the clinician can match wavelength and settings to the tissue and the treatment goal.

650

Superficial tissue, 650 nm

Red light, absorbed closer to the surface.

810

Deep tissue, 810 nm

Near-infrared light. The 800–810 nm band is the most studied in photobiomodulation research, where absorption by cytochrome c oxidase is the proposed mechanism.

980

Water and hemoglobin, 980 nm

Accelerates microcirculation and oxygen delivery, suited to advanced deep-tissue healing protocols.

HOW VOLTA F3 WORKS

 

From assessment to review

 

01

Assess

The clinician assesses the patient and decides whether photobiomodulation is appropriate.

02

Select a protocol

Choose from the ready-made treatment protocols built into the device.

03

Set parameters

Confirm or fine-tune output and time, independently on each wavelength.

04

Treat and review

Deliver the session and review progress against the treatment plan.

CONTROL AND SAFETY

 

The clinician sets the protocol

 

  • 650, 810 and 980 nm are each independently controlled, alone or in any combination.

  • Wavelength, output and treatment time are selected by the treating clinician.

  • Operation by trained healthcare professionals only.

  • Appropriate laser safety eyewear for operator and patient during treatment.

  • Training on safe use is provided with every installation.

QUALITY AND REGULATORY

 

Standards and registration

 

CE marking
ISO 13485 certified, medical devices quality management
FDA
Medical Device Authority Malaysia

Registered with the Medical Device Authority, Malaysia. MDA registration GC6440126-238777.

TREATMENT PRINCIPLES AND EDUCATION

 

Learn the principles behind the protocol

 

Technical education for clinicians who want to see how wavelength, dose and technique fit together.

Clinical applications

Where clinicians use VOLTA F3 in daily practice.

Evidence

Research summaries and scientific literature.

VOLTA Academy

Training and education for your clinical team.

CONTACT

 

Questions about the technology?

 

03-7499 3373 | info@voltalaser.com
VOLTA LASER SDN. BHD.
Address: 8, Jalan 12/152,
Taman Perindustrian OUG,
58200 Kuala Lumpur

 

MDA registration GC6440126-238777. VOLTA F3 is intended for use by qualified healthcare professionals. Whether photobiomodulation is appropriate for a specific patient is a decision for the treating clinician.

© 2026 VOLTA Laser Sdn. Bhd. · MDA GC6440126-238777

bottom of page